Browse Category

NASDAQ:INBS News 31 December 2025 - 2 January 2026

INBS stock drops today as Intelligent Bio Solutions’ $10M private placement puts dilution in focus

INBS stock drops today as Intelligent Bio Solutions’ $10M private placement puts dilution in focus

NEW YORK, Jan 2, 2026, 11:40 ET — Regular session Shares of Intelligent Bio Solutions Inc slid on Friday as investors digested the micro-cap medtech company’s $10 million private placement announced late Wednesday. The stock was down 12.1% at $8.38 by 11:25 a.m. ET. Benzinga The pullback comes after the stock more than doubled on Dec. 31 following news of…
INBS stock whipsaws after Intelligent Bio Solutions lines up $10 million funding

INBS stock whipsaws after Intelligent Bio Solutions lines up $10 million funding

NEW YORK, January 1, 2026, 03:10 ET — Market closed Intelligent Bio Solutions Inc said late Wednesday it will raise about $10 million in a private placement, sending its shares lower in after-hours trading after a sharp rally earlier in the session. The financing lands as the micro-cap medtech company pitches a faster path to scale for its fingerprint-based drug…
INBS stock jumps on Syrma Johari deal: Intelligent Bio Solutions targets 40% cost cuts

INBS stock jumps on Syrma Johari deal: Intelligent Bio Solutions targets 40% cost cuts

NEW YORK, December 31, 2025, 5:04 PM ET — After-hours Shares of Intelligent Bio Solutions Inc more than doubled in Wednesday’s regular session as investors piled into the micro-cap medical technology stock on a fresh manufacturing update. The stock closed at $9.53, up $5.43 from Tuesday’s close of $4.10, and traded at $8.95 in after-hours dealings. The shares ranged from…
INBS stock surges 160% as Intelligent Bio Solutions strikes manufacturing deal targeting 40% cost cuts

INBS stock surges 160% as Intelligent Bio Solutions strikes manufacturing deal targeting 40% cost cuts

NEW YORK, December 31, 2025, 13:04 ET — Regular session Intelligent Bio Solutions Inc shares surged on Wednesday after the company said it struck a new manufacturing partnership aimed at lowering costs for its fingerprint-based drug testing device. The stock was up $6.56, or about 160%, at $10.66 by 1:04 p.m. ET. Google The announcement matters now because Intelligent Bio…

Stock Market Today

  • Allison Transmission (ALSN) Shares Surge Amid Conflicting Valuation Signals
    January 30, 2026, 1:58 PM EST. Shares of Allison Transmission Holdings (ALSN) rose 12.8% in the past month and 35.1% over three months, reversing a 4.9% decline over one year. The stock trades near $111.56, above a popular fair value estimate of $100.20, suggesting it may be overvalued by 11.3%. This valuation gap stems from optimism around its electrified powertrain growth, including hybrid bus and defense transmission orders, against risks like softening medium-duty truck demand and integration challenges from its Dana acquisition. In contrast, a discounted cash flow model values ALSN shares much higher at $256.55, implying a 56.5% undervaluation versus current prices. Investors face a fundamental question on which valuation view better reflects future cash flows and growth prospects in the aerospace and defense sectors.
Go toTop